Myungmoon Phar - Asset Resilience Ratio

Latest as of September 2025: 0.10%

Myungmoon Phar (017180) has an Asset Resilience Ratio of 0.10% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 017180 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩280.03 Million

≈ $189.77K USD Cash + Short-term Investments

Total Assets

₩270.19 Billion

≈ $183.11 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2024)

This chart shows how Myungmoon Phar's Asset Resilience Ratio has changed over time. See Myungmoon Phar net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Myungmoon Phar's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Myungmoon Phar stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩280.03 Million	0.1%
Total Liquid Assets	₩280.03 Million	0.10%

Asset Resilience Insights

Limited Liquidity: Myungmoon Phar maintains only 0.10% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Myungmoon Phar Industry Peers by Asset Resilience Ratio

Compare Myungmoon Phar's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Daihan Pharmaceutical Co.Ltd KQ:023910	Drug Manufacturers - Specialty & Generic	11.95%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	16.92%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	Drug Manufacturers - Specialty & Generic	5.22%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Zhejiang Xianju Pharmaceutical Co Ltd SHE:002332	Drug Manufacturers - Specialty & Generic	6.02%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Hainan Honz Pharmaceutical Co SHE:300086	Drug Manufacturers - Specialty & Generic	0.27%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%

Annual Asset Resilience Ratio for Myungmoon Phar (2009–2024)

The table below shows the annual Asset Resilience Ratio data for Myungmoon Phar.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.14%	₩365.41 Million ≈ $247.63K	₩257.99 Billion ≈ $174.83 Million	-1.42pp
2023-12-31	1.57%	₩3.70 Billion ≈ $2.51 Million	₩236.55 Billion ≈ $160.31 Million	-0.66pp
2022-12-31	2.22%	₩5.13 Billion ≈ $3.47 Million	₩230.45 Billion ≈ $156.17 Million	+0.56pp
2021-12-31	1.66%	₩3.70 Billion ≈ $2.51 Million	₩222.68 Billion ≈ $150.90 Million	-1.85pp
2020-12-31	3.51%	₩8.53 Billion ≈ $5.78 Million	₩243.03 Billion ≈ $164.69 Million	+0.41pp
2019-12-31	3.10%	₩8.19 Billion ≈ $5.55 Million	₩264.44 Billion ≈ $179.21 Million	-0.35pp
2018-12-31	3.45%	₩8.39 Billion ≈ $5.68 Million	₩243.07 Billion ≈ $164.72 Million	+0.29pp
2017-12-31	3.16%	₩7.43 Billion ≈ $5.03 Million	₩235.08 Billion ≈ $159.31 Million	+1.07pp
2016-12-31	2.09%	₩4.62 Billion ≈ $3.13 Million	₩221.08 Billion ≈ $149.82 Million	-0.97pp
2015-12-31	3.07%	₩6.11 Billion ≈ $4.14 Million	₩199.42 Billion ≈ $135.14 Million	-1.22pp
2014-12-31	4.28%	₩8.17 Billion ≈ $5.53 Million	₩190.66 Billion ≈ $129.21 Million	-0.35pp
2013-12-31	4.64%	₩8.92 Billion ≈ $6.05 Million	₩192.41 Billion ≈ $130.39 Million	+0.53pp
2012-12-31	4.10%	₩7.73 Billion ≈ $5.24 Million	₩188.34 Billion ≈ $127.63 Million	+1.93pp
2011-12-31	2.18%	₩4.41 Billion ≈ $2.99 Million	₩202.50 Billion ≈ $137.23 Million	-3.91pp
2010-12-31	6.08%	₩9.99 Billion ≈ $6.77 Million	₩164.15 Billion ≈ $111.24 Million	+5.50pp
2009-12-31	0.58%	₩890.00 Million ≈ $603.14K	₩153.85 Billion ≈ $104.26 Million	--

pp = percentage points

About Myungmoon Phar

KO:017180 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$40.51 Million

₩59.77 Billion KRW

Market Cap Rank

#22651 Global

#1545 in Korea

Share Price

₩1788.00

Change (1 day)

+0.00%

52-Week Range

₩1581.00 - ₩1945.00

All Time High

₩10277.86